<i>Med Research</i>: Building Interdisciplinary Bridges and Leading Global Medical Innovation

The field of human health is confronting unprecedented historic decisions. Breakthrough advances in contemporary medicine are fundamentally reshaping our understanding of disease and treatment paradigms: gene editing technology based on the clustered regularly interspaced short palindromic repeats-associated protein 9(CRISPR-Cas9) system now enables precise modification of pathogenic gene loci [1]; deep learning-driven medical image analysis significantly enhances early lesion detection capabilities, dramatically improving diagnostic accuracy [2]; and single-cell transcriptome sequencing systematically unveils the complex heterogeneity of human cellular functions [3]. However, there exists a significant imbalance between technological innovation and global health equity—breast cancer 5-year survival rates exceed 90% in high-income countries [4], whereas the burden of childhood infectious diseases remains persistently high in sub-Saharan Africa [5]; Simultaneously, as the da Vinci surgical robot achieves operational precision at the 0.1 mm level, low-income countries still face substantial gaps in even basic obstetric care coverage [6]. This structural contradiction, where technological inclusivity substantially lags behind the pace of scientific breakthroughs, has become a critical challenge for global health governance in the 21st century. The current medical research ecosystem faces multidimensional and interconnected challenges. Knowledge barriers resulting from disciplinary divisions have not been completely eliminated—basic scientists search for clues in the labyrinth of molecular mechanisms, clinicians identify patterns in vast repositories of case data, and public health decision-makers seek balance amid waves of emergent crises. Despite sharing the ultimate goal of improving human health, differences in disciplinary languages and methodological approaches often render collaboration difficult. Of greater concern is that the translational efficiency of academic achievements still falls significantly short of expectations: valuable research may miss optimal application windows due to publication delays or fail to reach regions in urgent need due to intractable language and resource barriers. When preclinical data for a new diabetes therapy require many years to enter practice guidelines [7], when research on neglected diseases progresses slowly due to insufficient commercial incentives [8], we recognize more clearly than ever that medical progress necessitates more open collaborative ecosystems and more agile knowledge dissemination mechanisms. As members of the global academic community, we clearly acknowledge the limitations of a single platform. The complex challenges of emerging infectious disease threats, chronic disease burdens, and imbalanced healthcare resource distribution necessarily demand the establishment of cross-domain collaborative mechanisms. The establishment of Med Research is not intended to disrupt existing systems, but rather to serve as a collaborative partner among countless explorers, adopting an open cooperative approach to build bridges between the profound mechanisms of basic research and the practical needs of clinical practice. We firmly believe that the true power of medicine lies in the dual breakthrough of deepening our understanding of disease mechanisms and promoting the inclusive translation of technological achievements—enabling the brilliance of gene sequencing technology to illuminate villages ravaged by tropical diseases, and the precision of artificial intelligence (AI)-driven diagnostics to benefit clinics in remote mountainous areas. By facilitating meaningful exchanges between cutting-edge technologies from developed countries and indigenous wisdom from developing nations, and by promoting intellectual interaction between molecular biologists and frontline physicians, each seemingly small spark of innovation will generate transformative impact through resonance within the global health network. The ultimate goal of medical research is to improve patients' quality of life, and achieving this goal urgently requires bridging the triple gap of “laboratory discovery-clinical translation-health inclusivity.” Med Research was established specifically to address this contemporary challenge. We adopt “innovation, rigor, and impact” as our multidimensional evaluation criteria, focusing on high-impact research that encompasses the entire spectrum of basic medicine, translational medicine, and clinical practice. In the vast landscape of medical exploration, Med Research positions itself along three strategic dimensions: knowledge integrator, translation facilitator, and equity advocate. Medical breakthroughs often emerge at the critical intersections of multiple disciplines [9]. The microscopic mechanisms revealed by molecular biology, the diagnostic and treatment experience accumulated by clinical medicine, and the population health models constructed by public health—these research dimensions, which should mutually support each other, often struggle to form synergy due to methodological differences and disciplinary discourse segregation. Med Research is committed to serving as a strategic fulcrum for interdisciplinary research, fostering in-depth dialog between research paradigms across diverse fields through innovative academic evaluation systems and dissemination mechanisms. We value both basic research that explores the essence of life and its potential for clinical translation; we pursue the empirical value of clinical observations while emphasizing their feedback effect on theoretical framework development. In the field of translational medicine, we establish bidirectional feedback mechanisms between laboratory research and clinical practice: ensuring the clinical applicability of basic discoveries while emphasizing the reverse driving force of clinical phenomena on theoretical advancement. We reject the utilitarian tendencies of “application-only” approaches, giving equal attention to basic research with long-term theoretical significance, while encouraging researchers to articulate the practical health benefits of their work. This academically balanced approach aims to bridge the long-standing cognitive divide between basic and clinical research paradigms. At the global health governance level, Med Research adheres to the principle of “knowledge inclusivity.” We direct the academic spotlight toward research gaps in neglected diseases, integrate intellectual capital from resource-limited regions, and highlight theoretical contributions from nonmainstream academic communities. This approach represents not only a concrete manifestation of disciplinary ethics but also a return to the essence of medicine—the value of human life should not be diminished by geographic location nor should the dignity of knowledge be stratified based on publication venue prestige. As a member of the global medical community, Med Research consistently acknowledges the limitations of a single platform. We aim to gradually enhance the “demand-driven, evidence-generating, and practice-translating” knowledge transformation framework through sustained interactions with academia, the medical community, and policymakers, thereby enabling medical research to transcend disciplinary barriers and foster a knowledge ecosystem for building a human health community. In accordance with this vision, Med Research's academic domain must embody both the height of mountains and the depth of oceans, pursuing both groundbreaking discoveries that rewrite textbooks and subtle findings that fill knowledge gaps. The journal accepts original research covering comprehensive methodological frameworks covering basic medical mechanism exploration, clinical trial result reporting, and rehabilitation medicine assessment. The journal publishes systematic reviews following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines that systematically integrate evidence for specific medical issues. Med Research encourages prospective commentaries on emerging technologies, medical policies, or ethical controversies. The journal incorporates research briefs focusing on methodological innovations or clinical anomalies. Med Research releases data reports with global sharing value, such as original data from multicenter clinical trials and rare disease biobank information. Furthermore, as an important pillar of the medical system, the journal establishes channels for nursing innovation research, accepting evidence-based studies that enhance clinical nursing quality, such as nursing intervention effectiveness evaluations, patient safety management model innovations, and continuity of care programs for chronic diseases. In summary, whether molecular biological discoveries revealing disease mechanisms, breakthrough data from early clinical trials, or proof-of-concept for disruptive medical technologies, any findings that advance medical progress are of core interest to this journal. Regarding research directions, we focus on breakthroughs in basic experiments related to new drug development and resistance mechanisms, with particular attention to therapeutic target discovery, drug delivery system optimization, and the analysis of resistance evolution patterns; we advance innovative clinical trial paradigms by prioritizing phase innovations in Phases 1–3 trial design and investigator-initiated research, whereas striving to perfect standardized collection systems for patient-reported outcomes and exploring data integration pathways that connect real-world evidence (REW) with randomized controlled trials; we establish standards for clinical cohort construction through prospective and retrospective multicenter studies, including biological sample collection specifications, phenotypic data standardization processes, and blockchain-enabled follow-up quality control schemes; we deepen global disease burden research by publishing regional disease burden analyses based on the Global Burden of Disease (GBD) methodology, carcinogen exposure attribution assessments, and cancer incidence prediction models. Additionally, we support the development and validation of innovative research tools, encompassing methodological innovations in bioinformatics applications, experimental technology platforms, and clinical prediction models [10]. Med Research is committed to establishing an open, collaborative, and responsible academic ecosystem. We advocate for the systematic integration of interdisciplinary research [11], mandating that manuscripts clearly indicate their theoretical relationship with existing research (supplementary, corrective, or disruptive) and encouraging authors to incorporate critical analyses from multidisciplinary perspectives in the discussion section. We prioritize research with clear scientific hypotheses and logical coherence, regardless of whether the findings confirm or refute the initial hypotheses. We have established independent review channels to assess the methodological rigor and potential insights derived from negative result papers, thereby mitigating publication bias. Furthermore, to promote the sustainable development of the academic community, we require authors to disclose comprehensively the limitations of experimental design (such as model selection rationale and statistical power assessment) and provide detailed raw data sharing plans. We implement joint review systems pairing senior scholars with early-career researchers to promote balance between academic tradition and innovative thinking. We conduct rigorous ethical reviews, implementing tiered evaluations for research involving human subjects, animal experiments, and artificial intelligence algorithms [12]. Quality control remains our solemn commitment to the academic community. Each submission will undergo thorough scientific review by interdisciplinary reviewer alliances and ethical calibration, ensuring that the research conforms to ethical standards across diverse cultural backgrounds. In the current context of deeply intertwined globalization and health inequities, Med Research upholds the core concept of “knowledge without boundaries, health for all” and is dedicated to driving a paradigm shift in medical research from elite discourse systems to global public goods. Our vision is firmly rooted in the health equity principles of the United Nations Sustainable Development Goals (SDGs) [13], with our mission being the construction of an open, inclusive, and responsible academic ecology, as we strive to become a global hub that bridges knowledge gaps, leads ethical practices, and safeguards academic inheritance. We firmly believe that the value of medical research should ultimately be measured by its tangible contribution to human health and well-being. To this end, we will prioritize support for research addressing neglected diseases, regional health crises, and the fundamental causes of health inequalities, ensuring that cutting-edge findings transcend geographical and economic barriers to benefit researchers and patients in resource-limited regions through comprehensive open access policies and multilingual dissemination mechanisms [14]. When confronted with ethical challenges posed by disruptive technologies, such as gene editing and AI diagnosis [15], we advocate for the establishment of interdisciplinary ethical assessment frameworks, requiring researchers to evaluate accessibility for vulnerable populations, potential impacts on ecosystems, and respect for indigenous medical wisdom concurrent with their pursuit of technological breakthroughs. In the realm of academic legacy, Med Research consistently upholds the faithful documentation of scientific history, positioning knowledge integrity as a cornerstone of research ethics. We leverage digital technology platforms to ensure long-term traceability and reproducibility of research data, implement retrospective outcome assessment mechanisms, and systematically monitor the clinical translation progress and societal impact of published research. We profoundly recognize that medical advancement necessitates the intergenerational transfer of knowledge, thus we specifically focus on capacity building for early-career scientists and researchers from low- and middle-income countries, empowering them to become emerging leaders in global health governance through methodological training and strategic allocation of academic resources. Throughout this endeavor, Med Research remains steadfastly committed to three nonnegotiable principles: medical knowledge must serve the collective welfare of humanity rather than privileged groups; the realization of health as a fundamental human right demands proactive engagement from the academic community [16]; and addressing the complex health challenges of the 21st century requires the integration of expertise that transcends disciplinary boundaries and geographical limitations. We are dedicated to constructing sustainable knowledge systems—ensuring that each breakthrough provides reproducible methodological frameworks for subsequent research, and that every dataset withstands rigorous scrutiny from both ethical and practical perspectives. Medical progress has always represented the crystallization of collective wisdom rather than a solo performance by individuals or singular platforms. Confronted with increasingly complex challenges in global health—from cross-border threats of emerging infectious diseases to the growing burden of chronic conditions [17] and from controversies in technological ethics to imbalances in healthcare resource allocation [18]—we need collaborative efforts that break disciplinary barriers and transcend geographical boundaries more than ever before. As a member of the global academic community, Med Research hereby extends an invitation to all researchers and practitioners dedicated to advancing human health. When you identify unconventional phenomena in experiments, encounter intractable problems in clinical practice, or develop unique insights in public health implementation, we sincerely invite you to document your observations and perspectives. The journal is committed to implementing a comprehensive interdisciplinary peer review process for all submissions, with each study undergoing a three-dimensional assessment of scientific rigor, clinical applicability, and societal impact. We do not position ourselves as arbiters of truth, but rather strive to establish platforms for equitable scientific discourse—where the latest breakthroughs from molecular biology laboratories can mutually validate clinical experiences from community hospitals, where technical solutions from AI algorithm engineers can engage in substantive dialog with philosophical reflections from bioethicists, and where technological innovations from high-resource regions can both inform and be informed by localized practical wisdom. The value of medical research extends beyond laboratory breakthroughs to encompass the realization of health equity at the bedside, in communities, and globally [19]. Therefore, we especially call upon basic scientists to direct more attention toward clinical treatment bottlenecks when exploring tumor microenvironments or gene editing mechanisms; clinicians to more thoroughly consider molecular biological breakthroughs when summarizing rare disease cases; and policymakers to further contemplate AI diagnostic ethics and health equity when planning healthcare resource allocation. Only through such expansion of cognitive dimensions can dispersed academic achievements be transformed into tangible public health gains—ranging from optimized clinical pathways that reduce maternal mortality, to innovative treatment protocols that improve cancer survival rates, and to systematic breakthroughs in primary healthcare accessibility. Med Research is dedicated to creating a decentralized global academic collaboration network—breaking down geographical barriers and language obstacles, enabling resource-constrained research to overcome dissemination challenges, and freeing interdisciplinary exchanges from the limitations of traditional evaluation frameworks. To realize this vision, we must squarely face the sources of medical innovation. We profoundly recognize that seeds of medical transformation often germinate in nonmainstream domains [20]: perhaps portable diagnostic tools refined by physicians in resource-scarce regions, theoretical hypotheses challenging existing paradigms, or cross-disciplinary intersections between artificial intelligence and ancient medical wisdom [21]. These seemingly peripheral explorations specifically require more inclusive academic ecosystems for their development and advancement. Within this ecosystem, basic scientists and clinicians will engage in critical discourse regarding the tension between “accessibility and innovation,” policymakers can directly access empirical feedback from frontline healthcare workers [22], and the technological advances of high-income countries and practical wisdom from low-income countries can achieve bidirectional validation through “knowledge mirroring platforms.” Through this multidimensional knowledge exchange, we can—with evidence as our foundation and empathy as our guide—collectively navigate toward a future where medical progress is not only manifested in theoretical breakthroughs and academic discoveries but also evidenced by improved neonatal survival rates in remote areas, enhanced quality of life for patients with chronic diseases, and therapeutic innovations emerging from interdisciplinary collaboration. The authors declare no conflicts of interest.